At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Butyric acids; Hexoses
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 02 Jul 1998 Profile reviewed
- 02 Jul 1998 No-Development-Reported for Cancer in France (Unknown route)
- 21 Dec 1994 Preclinical development for Cancer in France (Unknown route)